The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed

Tools

Item Type:	Article
Title:	The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed
Creators Name:	Popovic, J., Li, L.P., Kloetzel, P.M., Leisegang, M., Uckert, W. and Blankenstein, T.
Abstract:	Adoptive therapy with T cell receptor (TCR)-engineered T cells is a promising approach in cancer treatment. While usage of T cells specific for tumor-associated antigens (TAAs) can lead to serious side effects due to autoimmunity, targeting true tumor-specific mutations, such as the products of translocations in leukemias, should reduce such a risk. A potentially ideal target might be the chimeric protein TEL-AML1, which results from the chromosomal translocation 12;21 and represents the most common fusion gene in childhood B cell precursor acute lymphoblastic leukemia (BCP-ALL). Within the fusion region of TEL-AML1, a single epitope has been described by reverse immunology as immunogenic in HLA-A0201 restriction settings. As a potential source of TCRs specific for this TEL-AML1 epitope, we have used mice expressing a human TCR-αβ repertoire and human major histocompatibility complex (MHC) class I. Surprisingly, we have found that, although a specific functional CD8(+) T cell response against this peptide could be evoked, the described epitope was in fact not endogenously processed. Analyses done with a potent antigen presenting cell line, as well as with purified human proteasomes, support the conclusion that this peptide cannot be proposed as a potential target in immunotherapy of ALL in HLA-A0201-restricted fashion.
Keywords:	Amino Acid Sequence, Antigen Presentation, Base Sequence, Cell Separation, Coculture Techniques, Core Binding Factor Alpha 2 Subunit, Flow Cytometry, Fusion Oncogene Proteins, Genetic Translocation, High Pressure Liquid Chromatography, Lymphocyte Activation, Molecular Sequence Data, T-Lymphocyte Epitopes, Transgenic Mice, Animals, Mice
Source:	Blood
ISSN:	0006-4971
Publisher:	American Society of Hematology
Volume:	118
Number:	4
Page Range:	946-954
Date:	28 July 2011
Official Publication:	https://doi.org/10.1182/blood-2010-12-325035
PubMed:	View item in PubMed

Repository Staff Only: item control page